Home › Companies › Nautilus Biotechnology, Inc. › 2025-2026
At Nautilus Biotechnology, Inc.'s shareholder meeting held June 17, 2026, in the 2025-2026 proxy season, 55 asset managers reported how they voted in their SEC Form N-PX filings, covering 230 separate fund positions. Their filings are grouped here into 5 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval on an advisory basis of the compensation of our named executive officers for the… — FOR was 99.6% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Nautilus Biotechnology, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 18, 2026.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Nautilus Biotechnology, Inc.’s Form 8-K, filed June 18, 2026 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 17, 2026: 4 items on Nautilus Biotechnology, Inc.’s Form 8-K, filed June 18, 2026: 2 elected · 1 approved · 1 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2025-2026
Explore Nautilus Biotechnology, Inc. in the interactive database Compare manager voting policies
These tallies are Nautilus Biotechnology, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 18, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Parag Mallick | 67,882,439 | -- | -- | 2,411,134 | 14,708,618 | 97% | Elected | — |
| Elect Director: Farzad Nazem | 67,994,844 | -- | -- | 2,298,729 | 14,708,618 | 97% | Elected | — |
| 2. Ratification of Appointment of Independent Registered Public Accounting Firm | 84,937,704 | 27,748 | 36,739 | -- | -- | 99.9% | Approved | — |
| 3. Advisory Vote on Executive Compensation: The vote to approve, on an advisory basis, the compensation of the Company's named executive officers for the fiscal year ended December 31, 2025 (the "Say on Pay Vote") | 69,994,022 | 268,341 | 31,210 | -- | 14,708,618 | 99.6% | Not verified | — |
Source: Nautilus Biotechnology, Inc., Form 8-K, filed with the SEC on June 18, 2026 — read the filing on EDGAR.
Each item below shows how the 55 asset managers that disclosed a Nautilus Biotechnology, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Nautilus Biotechnology, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 5 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors: Farzad Nazem
Nautilus Biotechnology, Inc.’s own tally for this item (“Elect Director: Farzad Nazem”): 67,994,844 for, 2,298,729 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following nominees were elected to serve as Class II directors, each to hold office until the Company's 2029 annual meeting of stockholders or until his respective successor has been duly elected and qualified:”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,505,161 | 0 | 4 | 3,668 | For |
| Fidelity | 499,287 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 130,000 | Withhold |
| Dimensional | 0 | 0 | 0 | 116,440 | Withhold |
| Goldman Sachs | 28,501 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 0 | 6,886 | Withhold |
| Jackson National | 0 | 0 | 5,558 | 0 | Abstain |
| Lincoln Financial | 0 | 0 | 0 | 5,121 | Withhold |
| MASTER INVESTMENT PORTFOLIO | 2,915 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 518 | Withhold |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 335 | Withhold |
Fund voting reports, all 11 managers: 3,035,864 for, 262,968 withheld, 5,562 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Crewe Advisors LLC | 136,052 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 136,052 for.
Combines 5 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors: Parag Mallick
Nautilus Biotechnology, Inc.’s own tally for this item (“Elect Director: Parag Mallick”): 67,882,439 for, 2,411,134 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following nominees were elected to serve as Class II directors, each to hold office until the Company's 2029 annual meeting of stockholders or until his respective successor has been duly elected and qualified:”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,505,161 | 0 | 4 | 3,668 | For |
| Fidelity | 499,287 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 130,000 | Withhold |
| Dimensional | 0 | 0 | 0 | 116,440 | Withhold |
| Goldman Sachs | 28,501 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 0 | 6,886 | Withhold |
| Jackson National | 0 | 0 | 5,558 | 0 | Abstain |
| Lincoln Financial | 0 | 0 | 0 | 5,121 | Withhold |
| MASTER INVESTMENT PORTFOLIO | 2,915 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 518 | Withhold |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 335 | Withhold |
Fund voting reports, all 11 managers: 3,035,864 for, 262,968 withheld, 5,562 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Crewe Advisors LLC | 136,052 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 136,052 for.
Combines 6 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
Description as filed by funds: Approval on an advisory basis of the compensation of our named executive officers for the fiscal year ended December 31, 2025 (the "Say on Pay Vote").
Nautilus Biotechnology, Inc.’s own tally for this item (“3. Advisory Vote on Executive Compensation: The vote to approve, on an advisory basis, the compensation of the Company's named executive officers for the fiscal year ended December 31, 2025 (the "Say on Pay Vote")”): 69,994,022 for, 268,341 against, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,508,833 | 0 | 0 | 0 | For |
| Fidelity | 499,287 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 130,000 | 0 | 0 | 0 | For |
| Dimensional | 116,440 | 0 | 0 | 0 | For |
| Goldman Sachs | 28,501 | 0 | 0 | 0 | For |
| Victory Capital | 6,886 | 0 | 0 | 0 | For |
| Jackson National | 5,558 | 0 | 0 | 0 | For |
| Lincoln Financial | 5,121 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,915 | 0 | 0 | 0 | For |
| American Century | 518 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 335 | 0 | 0 | Against |
Fund voting reports, all 11 managers: 3,304,059 for, 335 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| a16z Capital Management, L.L.C. | 17,653,917 | 0 | 0 | 0 | For |
| PERCEPTIVE ADVISORS LLC | 11,889,327 | 0 | 0 | 0 | For |
| Cercano Management LLC | 7,172,985 | 0 | 0 | 0 | For |
| Clearstead Advisors, LLC | 664,273 | 0 | 0 | 0 | For |
| ACADIAN ASSET MANAGEMENT LLC | 655,648 | 5,338 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 606,505 | 0 | 0 | 0 | For |
| Vanguard | 322,340 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 267,680 | 0 | 0 | 0 | For |
| Renaissance | 220,636 | 0 | 0 | 0 | For |
| State Street | 216,270 | 0 | 0 | 0 | For |
| BlackRock | 190,681 | 0 | 0 | 0 | For |
| Crewe Advisors LLC | 136,052 | 0 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 130,000 | 0 | 0 | 0 | For |
| Northern Trust | 99,384 | 0 | 0 | 0 | For |
| Dimensional | 92,691 | 0 | 0 | 0 | For |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 46,923 | 0 | 0 | 0 | For |
| Point72 | 45,457 | 0 | 0 | 0 | For |
| Corient Private Wealth LP | 45,350 | 0 | 0 | 0 | For |
| FAYEZ SAROFIM & CO | 45,000 | 0 | 0 | 0 | For |
| Badgley Phelps Wealth Managers, LLC | 30,000 | 0 | 0 | 0 | For |
| CAPTRUST FINANCIAL ADVISORS | 30,000 | 0 | 0 | 0 | For |
| Callan Family Office, LLC | 25,970 | 0 | 0 | 0 | For |
| Hudson Bay Capital Management LP | 24,344 | 0 | 0 | 0 | For |
| D.A. DAVIDSON & CO. | 14,814 | 0 | 0 | 0 | For |
| BALYASNY ASSET MANAGEMENT L.P. | 13,520 | 0 | 0 | 0 | For |
Institutional-manager reports, all 47 managers: 40,707,723 for, 5,673 against, 2,300 not voted. Showing the 25 largest; every one is in the interactive database (link above).
100% Fund and manager reports combined; may count the same shares twice · no official result
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 0 | -- |
| Dimensional | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| Victory Capital | 0 | 0 | 0 | 0 | -- |
| Jackson National | 0 | 0 | 0 | 0 | -- |
| Lincoln Financial | 0 | 0 | 0 | 0 | -- |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 0 | -- |
| American Century | 0 | 0 | 0 | 0 | -- |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 11 managers: 3,177,202 1 year, 127,119 3 year, 73 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| a16z Capital Management, L.L.C. | 0 | 0 | 0 | 0 | -- |
| PERCEPTIVE ADVISORS LLC | 11,889,327 | 0 | 0 | 0 | For |
| Cercano Management LLC | 0 | 0 | 0 | 0 | -- |
| Clearstead Advisors, LLC | 0 | 0 | 0 | 0 | -- |
| ACADIAN ASSET MANAGEMENT LLC | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| MARSHALL WACE, LLP | 0 | 0 | 0 | 0 | -- |
| Renaissance | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Crewe Advisors LLC | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Dimensional | 0 | 0 | 0 | 0 | -- |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 0 | 0 | 0 | 0 | -- |
| Point72 | 0 | 0 | 0 | 0 | -- |
| Corient Private Wealth LP | 0 | 0 | 0 | 0 | -- |
| FAYEZ SAROFIM & CO | 0 | 0 | 0 | 0 | -- |
| Badgley Phelps Wealth Managers, LLC | 0 | 0 | 0 | 0 | -- |
| CAPTRUST FINANCIAL ADVISORS | 0 | 0 | 0 | 0 | -- |
| Callan Family Office, LLC | 0 | 0 | 0 | 0 | -- |
| Hudson Bay Capital Management LP | 0 | 0 | 0 | 0 | -- |
| D.A. DAVIDSON & CO. | 0 | 0 | 0 | 0 | -- |
| BALYASNY ASSET MANAGEMENT L.P. | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 46 managers: 11,889,327 for, 2,300 not voted, 28,730,378 1 year, 92,691 3 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Description as filed by funds: Ratification of the appointment of PricewaterhouseCoopers, LLP as our independent registered public accounting firm for the year ended December 31, 2026.
Nautilus Biotechnology, Inc.’s own tally for this item (“2. Ratification of Appointment of Independent Registered Public Accounting Firm”): 84,937,704 for, 27,748 against — passed, per its Form 8-K filed June 18, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified based on the following results of voting:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,508,833 | 0 | 0 | 0 | For |
| Fidelity | 499,287 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 130,000 | 0 | 0 | 0 | For |
| Dimensional | 116,440 | 0 | 0 | 0 | For |
| Goldman Sachs | 28,501 | 0 | 0 | 0 | For |
| Victory Capital | 6,886 | 0 | 0 | 0 | For |
| Jackson National | 5,558 | 0 | 0 | 0 | For |
| Lincoln Financial | 5,121 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,915 | 0 | 0 | 0 | For |
| American Century | 518 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 335 | 0 | 0 | 0 | For |
Fund voting reports, all 11 managers: 3,304,394 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Crewe Advisors LLC | 136,052 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 136,052 for.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 127,078,855 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 1.97% |
| 2 | Fidelity | 0.39% |
| 3 | BRIDGEWAY FUNDS INC | 0.10% |
| 4 | Dimensional | 0.09% |
| 5 | Goldman Sachs | 0.02% |
| 6 | Victory Capital | <0.01% |
| 7 | Jackson National | <0.01% |
| 8 | Lincoln Financial | <0.01% |
| 9 | MASTER INVESTMENT PORTFOLIO | <0.01% |
| 10 | American Century | <0.01% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | a16z Capital Management, L.L.C. | 13.89% |
| 2 | PERCEPTIVE ADVISORS LLC | 9.36% |
| 3 | Cercano Management LLC | 5.64% |
| 4 | Clearstead Advisors, LLC | 0.52% |
| 5 | ACADIAN ASSET MANAGEMENT LLC | 0.52% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 0.48% |
| 7 | Vanguard | 0.25% |
| 8 | MARSHALL WACE, LLP | 0.21% |
| 9 | Renaissance | 0.17% |
| 10 | State Street | 0.17% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Parag Mallick | 17.75% | 13D |
| Sujal Patel | 16.72% | 13D |
| Entities affiliated with Andreessen Horowitz | 13.89% | DEF14A |
| Perceptive Life Sciences Master Fund Ltd. | 9.91% | DEF14A |
| Entities affiliated with Cercano Management | 5.64% | DEF14A |
| Entities affiliated with Madrona Ventures | 5.30% | DEF14A |
| Matthew McIlwain | 5.30% | DEF14A |
| Marc L. Andreessen | 4.93% | 13D |
| Perceptive Advisors LLC | 3.89% | 13D |
| Vanguard Group | 2.04% | 13F |
Percentages above are of 127,078,855 shares outstanding, as reported by Nautilus Biotechnology, Inc. on its Form 10-Q dated April 23, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Nautilus Biotechnology, Inc.’s 10-Q dated April 23, 2026. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
Nautilus Biotechnology, Inc. proxy season coverage: 2025-2026 (this page).
proxyvotesnow.com, “Nautilus Biotechnology (NAUT) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/nautilus-biotechnology-inc/2026 (version of November 9, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.